The goal of this interrupted time-series analysis is to evaluate the impact of the de-implementation of urine dipsticks as a diagnostic tool for urinary tract infections (UTIs) in hospitalized patients in the North Denmark Region. The main question it aims to answer is: How does de-implementation of urine dipsticks affect the diagnosis and management of UTIs and related disorders? Specifically, does it change the following parameters: * Number and severity of UTI infections (lower and upper UTI, non-severe and severe) * Antibiotic prescription (overall, antibiotic classes, administration routes, duration, dosages) * Number of urine cultures and number of positive urine cultures * Risks of admission to intensive care units and 30-day mortality * Risk of drug toxicity * Length of hospital stay * Risk of admission to intensive care unit * 30-day risk of readmission after discharge * 6-month risks of Clostridioides difficile enterocolitis and de novo antimicrobial resistance in cultures obtained during routine clinical care. Researchers hypothesize that de-implementing urine dipsticks will lead to a reduced frequency of diagnosed cystitis, reduced antibiotic use, and fewer urine cultures without negatively affecting patient mortality or readmission risk. Researchers will compare the outcomes before and after the discontinuation of urine dipsticks across hospitals in the North Denmark Region. Furthermore, results will be compared to another Danish administrative healthcare region where dipsticks are still in use as well as urine culture data from the primary sector in the North Denmark Region. Since this is a registry-based observational study utilizing data from the electronic patient record system in the North Denmark Region, no direct contact will be made with participants.
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Monthly Incidence Rate of Urinary Tract Diagnoses (Composite Measure)
Timeframe: The monthly incidence will be calculated between January 2019 to end of the study (September 2025)
Monthly Incidence Rate of Urine Cultures (Composite Measure)
Timeframe: The monthly incidence will be calculated between January 2019 to end of the study period (September 2025)
Monthly Incidence Rate of Antibiotic Usage (Composite Measure)
Timeframe: The monthly incidence rate will be calculated between January 2019 to end of the study period (September 2025)
Monthly Mortality Rate (Composite Measure)
Timeframe: The monthly mortality rate will be calculated between January 2019 to end of the study period (September 2025)
Monthly Incidence Rate of Readmissions (Composite Measure)
Timeframe: The monthly incidence rate of readmissions will be calculated between January 2019 and the end of the study period (September 2025)
Median Length of Hospital Stay
Timeframe: The monthly median will be calculated from January 2019 to the end of the study period (September 2025).